Human-Animal Chimera Prohibition Act of 2025

Bill Number: H.R. 2161
Origin Chamber: House
Congress: 119th Congress, Session 1
Policy Area: Crime and Law Enforcement
Status: Introduced
Latest Action: 2025-03-14: Referred to the House Committee on the Judiciary.
Last Updated: 2025-04-01T17:34:27Z

AI-Generated Summary

Purpose

The Human-Animal Chimera Prohibition Act of 2025 aims to ban the creation, transfer, and transportation of specific types of human-animal hybrids (chimeras) that blur the biological boundaries between humans and animals, particularly in embryonic or developmental stages. It seeks to prevent scientific or medical practices that could result in organisms with uncertain human species membership or human-like features in nonhumans.

Key Provisions

Definitions:
A "prohibited human-animal chimera" includes various engineered or mixed entities, such as:
Human embryos altered with nonhuman cells that make their human species status unclear.
Embryos from fertilizing human eggs with nonhuman sperm, or nonhuman eggs with human sperm.
Embryos with chromosomes from both human and nonhuman sources.
Nonhuman organisms engineered to develop human reproductive cells (gametes), contain a human-like brain, or exhibit human facial or body features.
Mixed-cell embryos that lead to human gamete development, human brains, or human-like morphologies.
A "human embryo" is defined as an early-stage Homo sapiens organism, from a single cell up to 8 weeks of development.

Prohibitions (under new 18 U.S.C. Chapter 52):
It is illegal for any person to knowingly create or attempt to create a prohibited chimera.
Bans transferring a human embryo into a nonhuman womb, or a nonhuman embryo into a human womb.
Prohibits transporting or receiving a prohibited chimera for any purpose.
These rules apply if the actions affect interstate commerce (e.g., cross-state research or shipping).

Penalties:
Criminal: Fines, up to 10 years in prison, or both for violations.
Civil: For violations involving financial gain, a fine of at least $1,000,000 or twice the gross profit, whichever is greater.

Exceptions:
Does not ban research using genetically modified animals with human genes (transgenic models) or transplanting human organs, tissues, or cells into animals, as long as these do not create prohibited chimeras.

Technical Update:
Adds the new chapter to the table of contents in Title 18 of the U.S. Code (the federal criminal code).

Significant Changes to Existing Law

Introduces entirely new federal criminal prohibitions in Title 18, U.S. Code, by creating Chapter 52 specifically targeting human-animal chimeras—previously unregulated at the federal level beyond general bioethics guidelines.
Expands federal oversight into biotechnology and embryonic research, shifting some activities from ethical recommendations (e.g., by the National Institutes of Health) to enforceable criminal law.
No prior specific bans on these chimeras existed in U.S. criminal code, though related areas like cloning or stem cell research have faced funding restrictions.

Potential Impacts

On Government Agencies: The Department of Justice and FBI would gain enforcement responsibilities, potentially increasing investigations into biotech labs. Agencies like the NIH or FDA might need to adjust research funding and oversight to comply, avoiding support for prohibited activities.
On Citizens and Researchers: Limits scientific experimentation in fields like regenerative medicine, stem cell therapy, and organ transplantation, potentially slowing innovation in treatments for diseases. Individuals or labs involved could face severe penalties, deterring risky research.
On International Relations: Could influence global biotech collaborations, as U.S. researchers might avoid partnering with countries lacking similar bans, or it may prompt international debates on bioethics standards. No direct impact on trade or diplomacy is specified.

Main Stakeholders Affected

Scientists and Researchers: Primary group impacted, especially those in embryology, genetics, and bioengineering, who may need to redesign experiments to avoid prohibited chimeras.
Biotechnology and Pharmaceutical Companies: Face compliance costs and risks of fines for developing therapies involving human-animal interactions.
Medical Professionals: Affected in areas like organ transplants or fertility treatments that involve cross-species elements.
Patients and Advocacy Groups: Potential beneficiaries if the law prevents unethical experiments, but could delay advancements in personalized medicine or disease modeling.
Religious and Ethical Organizations: Likely supporters, given concerns over "playing God" with human-animal boundaries.

Notable Legal, Constitutional, or Political Implications

Legal: Establishes clear criminal liability for biotech activities affecting interstate commerce, invoking Congress's Commerce Clause authority (Article I, Section 8 of the Constitution) to regulate. The broad definitions may lead to court challenges over vagueness—what counts as "uncertain" species membership or "human-like" features.
Constitutional: Could raise free speech or academic freedom issues if interpreted to restrict scientific discourse, though it targets actions, not ideas. No direct conflict with privacy rights (e.g., reproductive choices) is evident, but embryo definitions might intersect with abortion-related precedents like Roe v. Wade overrulings.
Political: Reflects ongoing debates on bioethics, with bipartisan sponsorship (Republicans) highlighting conservative values on human dignity. May fuel polarization between pro-life groups (supportive) and scientific communities (opposed to innovation barriers), potentially influencing future funding for biomedical research.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Smith, Christopher H. [R-NJ-4]

Cosponsors (3)

Rep. Harris, Andy [R-MD-1], Rep. Miller, Mary E. [R-IL-15], Rep. Aderholt, Robert B. [R-AL-4]

Recent Actions

2025-03-14: Referred to the House Committee on the Judiciary.
2025-03-14: Introduced in House
2025-03-14: Introduced in House

Bill Versions

Human-Animal Chimera Prohibition Act of 2025 — issued 2025-03-14 — PDF (5 pages)